Chelator-Based Contrast Agents for Metal Ion Detection
Solution Overview
Problem
Current contrast agents for imaging techniques such as MRI, PET, CT, X-ray, SPECT, and ultrasound lack specificity and efficiency in detecting targets like zinc and human serum albumin in vivo, particularly in diagnostic and therapeutic applications.
Innovation Solution
Development of chelator groups with a target binding unit, capable of binding metal ions and proteins, generating detectable signals through changes in relaxometric, luminescent, or radioactive properties, using macrocycle structures with heteroatoms and specific metal ions like Gd3+, Eu3+, and In3+, and incorporating binding moieties like N,N′-bis-2-pyridyl methyl amine (BPMA) for enhanced signal generation and target interaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional contrast agents are used for imaging, then imaging can be performed, but the agents lack specificity and efficiency in detecting targets like zinc and human serum albumin
Solution Approach 1:
The contrast agent is divided into separate functional modules: a chelator group for metal ion binding, a binding moiety for target protein interaction, and a signal-generating unit. This segmentation allows each component to be optimized independently for its specific function, improving both specificity and efficiency of target detection
Solution Approach 2:
The invention creates composite contrast agents by combining multiple functional units (chelator, binding moiety, signal generator) into a single molecular entity. This composite structure enables simultaneous metal ion chelation, target protein binding, and enhanced signal generation, resolving the contradiction between specificity and efficiency
2Measurement precision
If contrast agents bind to targets in vivo, then signal detection is enabled, but the agents require complex chelator groups with macrocycle structures and multiple heteroatoms
Solution Approach 1:
The chelator group is designed with macrocycle structures containing multiple heteroatoms that can coordinate with various metal ions (Gd3+, Eu3+, In3+, etc.), providing universal metal binding capability. This multi-functionality reduces the need for multiple different chelator designs, simplifying the overall approach despite the complex individual molecular structure
Solution Approach 2:
The invention optimizes specific parameters of the chelator group (macrocycle ring size, heteroatom types and positions, substituent groups) to achieve optimal metal ion binding affinity and signal generation properties. By carefully tuning these parameters, high detection accuracy is achieved while avoiding unnecessary structural complexity
3Reliability
If binding moieties like BPMA are incorporated for enhanced target interaction, then binding affinity increases, but the synthesis process becomes more complex requiring coupling agents and multiple steps
Solution Approach 1:
The binding moiety (e.g., BPMA) is pre-synthesized as a separate, stable intermediate compound with defined structure and properties. This preliminary preparation allows for optimization of binding affinity independent of the chelator synthesis, and the pre-formed building block can be coupled to the chelator in a single definitive step, simplifying the overall manufacturing process despite the complexity of the final molecule
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution enables precise detection and imaging of targets in vivo by altering signal properties upon binding, allowing for accurate localization and quantification of metal ions and proteins, even at low concentrations, facilitating diagnostic and therapeutic applications.
Implementation Method 1
a chelator group, a binding moiety covalently attached to the chelator group, wherein the binding moiety is capable of binding a target
Implementation Method 2
the metal ion can be at least one paramagnetic metal such as Gd3+, Eu3+, Tm3+, Dy3+, Tb3+, Yb3+, Mn2+
Implementation Method 3
For diagnostic by MRI Gd3+, Eu3+, Tm3+, Dy3+, Tb3+, Yb3+ and Mn2+ are preferred
Implementation Method 4
A radioactive metal such as 111In3+, 113mIn3+, 67Ga3+, 68Ga3+, 99mTc4+, 64Cu2+, Tl3+, 153Sm3+, 166Ho3+ and 212Bi3+
Implementation Method 5
the binding moiety is capable of binding a target further binding a protein in vivo such as human serum albumin
Data Source
AI summary
This invention includes agents and compositions having MRI, PET, CT, X-ray, SPECT or optical signals, and methods for their use in the determination of a target. In some cases, a MRI, PET, CT, X-ray, SPECT, optical or other signal produced by the agent or composition can be affected by the presence of the target. Examples of targets that can be determined by this invention include, but are not limited to zinc, copper, iron ions and other biological targets. Example of application for imaging in vivo includes the function of pancreas and other organs.



